文献速递糖尿病

根据IADPSG/WHO 2013标准,欧洲肥胖孕妇妊娠期糖尿病的流行病学研究

Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe.
PubMed 文献 · Diabetologia · 2017-07-12

该研究纳入欧洲11个中心BMI≥29 kg/m2的孕妇1023例,采用IADPSG/WHO 2013标准诊断妊娠期糖尿病(GDM)。结果显示39%的孕妇发生GDM,各国患病率无显著差异,且既往GDM史、先天畸形和巨大儿史在GDM组更常见。

要点

  • BMI≥29 kg/m2的欧洲孕妇中,39%发生GDM。
  • 孕早期GDM患病率为24%(242/1023)。
  • 既往GDM史、先天畸形和巨大儿史与GDM发生相关。

核心结论

  • 采用IADPSG/WHO 2013标准,欧洲BMI≥29.0 kg/m2孕妇的GDM患病率较高,对母婴健康构成显著负担。
  • 亟需统一的GDM诊断标准和有力的治疗获益证据来指导现代GDM筛查和治疗策略。

研究设计与样本

  • 研究为泛欧洲多中心试验(DALI)的试点、生活方式和维生素D研究的队列分析,纳入11个中心BMI≥29.0 kg/m2的孕妇1023例(86.3%为欧洲裔)。
  • 收集入组时及整个孕期的 demographic、人体测量和代谢数据,采用IADPSG/WHO 2013标准诊断GDM,GDM治疗遵循当地政策。

主要发现

  • 各国招募人数为80至217例,失访率为7.1%。
  • 总体39%的孕妇发生GDM,各国患病率无显著差异。
  • 孕早期GDM患病率为24%(242/1023);尽管DALI研究采取了干预措施,孕中期(24-28周)检测时又有14%(94/672)发生GDM,孕晚期(35-37周)剩余队列中13%(59/476)发生GDM。
  • GDM组与维持正常糖耐量组在基线时的人口学和生活方式因素相似。
  • GDM组报告既往GDM史(16.5% vs 7.9%,p=0.002)、先天畸形(6.4% vs 3.3%,p=0.045)和巨大儿史(31.4% vs 17.9%,p=0.001)的比例更高。

关键数值与推荐

  • GDM诊断采用IADPSG/WHO 2013标准。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Accurate prevalence estimates for gestational diabetes mellitus (GDM) among pregnant women in Europe are lacking owing to the use of a multitude of diagnostic criteria and screening strategies in both high-risk women and the general pregnant population. Our aims were to report important risk factors for GDM development and calculate the prevalence of GDM in a cohort of women with BMI ≥29 kg/m2 across 11 centres in Europe using the International Association of the Diabetes and Pregnancy Study Groups (IADPSG)/WHO 2013 diagnostic criteria. METHODS: Pregnant women (n = 1023, 86.3% European ethnicity) with a BMI ≥29.0 kg/m2 enrolled into the Vitamin D and Lifestyle Intervention for GDM Prevention (DALI) pilot, lifestyle and vitamin D studies of this pan-European multicentre trial, attended for an OGTT during pregnancy. Demographic, anthropometric and metabolic data were collected at enrolment and throughout pregnancy. GDM was diagnosed using IADPSG/WHO 2013 criteria. GDM treatment followed local policies. RESULTS: The number of women recruited per country ranged from 80 to 217, and the dropout rate was 7.1%. Overall, 39% of women developed GDM during pregnancy, with no significant differences in prevalence across countries. The prevalence of GDM was high (24%; 242/1023) in early pregnancy. Despite interventions used in the DALI study, a further 14% (94/672) had developed GDM when tested at mid gestation (24-28 weeks) and 13% (59/476) of the remaining cohort at late gestation (35-37 weeks). Demographics and lifestyle factors were similar at baseline between women with GDM and those who maintained normal glucose tolerance. Previous GDM (16.5% vs 7.9%, p = 0.002), congenital malformations (6.4% vs 3.3%, p = 0.045) and a baby with macrosomia (31.4% vs 17.9%, p = 0.001) were reported more frequently in those who developed GDM. Significant anthropometric and metabolic differences were already present in early pregnancy between women who developed GDM and those who did not. CONCLUSIONS/INTERPRETATION: The prevalence of GDM diagnosed by the IADPSG/WHO 2013 GDM criteria in European pregnant women with a BMI ≥29.0 kg/m2 is substantial, and poses a significant health burden to these pregnancies and to the future health of the mother and her offspring. Uniform criteria for GDM diagnosis, supported by robust evidence for the benefits of treatment, are urgently needed to guide modern GDM screening and treatment strategies.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Egan AM, Vellinga A, Harreiter J, et al. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe. Diabetologia. 2017. PMID: 28702810. doi:10.1007/s00125-017-4353-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。